You are using an UNSUPPORTED version of browser, please try to update your browser.

City Record 311 Search all NYC.gov websites
Advanced

Notice Details

Title: Observational Study of Monkeypox Immunity (OSMI)
Procurement
Health and Mental Hygiene (DOHMH)
New York University School of Medicine Administrative Unit
650 1st Avenue , New York, NY, 10016
Services (other than human services)
Negotiated Acquisition
3/1/2024
Award
$200,000.00

PIN#81623N0051001

In 1962, NIAID established Vaccine and Treatment Evaluation Units (VTEUs) to provide a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases. There are ten VTEUs nation-wide, with one in NYC, which is New York University School of Medicine. The VTEUs were established, in part, as a rapid response network to ensure the capability to test vaccines designed to counteract emerging public health concerns. An important strength of the VTEUs is their ability to enroll large numbers of volunteers into trials rapidly and vaccinate them in a safe, effective and quick manner. They provide a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases. The Agency has determined that it is in the best interest of the City to utilize a Negotiated Acquisition method of source selection directly with NYU as there are no other organizations or entities that have The National institute of Allergy and Infectious Diseases (NIAID)’s depth and breadth of experience in conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.
Description

DOHMH intends to enter into a limited pool Negotiated Acquisition with NYU School of Medicine (through its Vaccine and Treatment Evaluation Units) to conduct studies on the Jynneos vaccine being used to respond to Monkey pox. The Vaccine and Treatment Evaluation Units (VTEUs) was established by The National institute of Allergy and Infectious Diseases (NIAID) to provide a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases. The VTEUs is a rapid response network to ensure the capability to test vaccines designed to counteract emerging public health concerns. For more than 60 years, NIAID has conducted and supported basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. This research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.

NYC Open Data Portal Contact Us

Disclaimer: Pursuant to Section 103 (2) of the New York State General Municipal Law, New York City Charter Section 1066 and the City of New York Procurement Policy Board Rules, The City Record is the official paper of the City of New York. It is published each weekday except legal holidays. The print edition of The City Record is the official publication for the following notices: public hearings, meetings, court notices, property dispositions, procurements (solicitations and awards), agency public hearings, agency rules, and special materials which include changes in personnel. This electronic version of The City Record is offered solely for the convenience of readers.